HIGHLIGHTS
- who: Int. J. Mol. Sci. and colleagues from the Department of Breast Surgery, Yamanashi Central Hospital, Kofu, JapanUniversity of Tokyo, Hongo, Bunkyo-ku, Tokyo, Japan have published the article: Molecular Sciences, in the Journal: (JOURNAL)
- what: The authors focused retrospectively on 346 patients (334 with breast and/or ovarian cancer sequenced at at the Yamanashi Central Hospital (YCH) with the purpose and 12 with prostate cancer) sequenced to compare the BRCA1 /2 variant interpretation provided by the current clinical workflow with those provided through reanalysis with the MH BRCA technology and to evaluate the predicted . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.